Prognostic impact of KRAS mutant type and MET amplification in metastatic and recurrent gastric cancer patients treated with first-line S-1 plus cisplatin chemotherapy.
KRAS 突变类型和 MET 扩增对接受一线 S-1 加顺铂化疗的转移性和复发性胃癌患者的预后影响
期刊:Genes and Cancer
影响因子:
doi:10.18632/genesandcancer.96
Matsusaka Satoshi, Kobunai Takashi, Yamamoto Noriko, Chin Keisho, Ogura Mariko, Tanaka Gotaro, Matsuoka Kazuaki, Ishikawa Yuichi, Mizunuma Nobuyuki, Yamaguchi Toshiharu
